BIMATOPROST STADA
0,3MG/ML OPH GTT SOL 3X3ML
Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
---|---|---|---|---|
Resumption of marketing | 09.11.2022 | |||
Interruption of marketing | 15.09.2022 |
0136717, 0203399, 0224006, 0224007, 0027543 |
Manufacturing reasons | 05.12.2022 |
Resumption of marketing | 07.10.2020 | |||
Interruption of marketing | 13.05.2019 |
0131292, 0136717, 0203399, 0027543 |
Manufacturing reasons | 31.7.2020 |
Resumption of marketing | 14.02.2017 | |||
Interruption of marketing | 16.01.2017 |
0027543 |
||
Placing on the market | 27.01.2016 |
All reports are available in the Overview.